Citation Impact
Citing Papers
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Targeted cell killing by reconstituted caspases
2007 StandoutNobel
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
CAR-dependent and CAR-independent pathways of adenovirus vector–mediated gene transfer and expression in human fibroblasts
1999
JNK Regulates HIPK3 Expression and Promotes Resistance to Fas-mediated Apoptosis in DU 145 Prostate Carcinoma Cells
2004
Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs
2016 Standout
Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases
2001
Modulation of Integrin Activation by an Entropic Spring in the β-Knee
2010 StandoutNobel
Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer
2004
Analysis of citrate in low-volume seminal fluid samples using a time-gated measurement of europium luminescence
2011
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)
2000
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines
1996
Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist
2011
Therapeutic uses of vitamin D analogues
2001
Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age
2007 Standout
Vitamin D Deficiency
2007 Standout
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
An essential role for Rxrα in the development of Th2 responses
2005 StandoutNobel
Update on chemoprevention of prostate cancer
2004
Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3–dependent signal transduction by phosphorylating human retinoid X receptor α
1999
The development of androgen-independent prostate cancer
2001 Standout
Ras-ERK MAPK Cascade Regulates GATA3 Stability and Th2 Differentiation through Ubiquitin-Proteasome Pathway
2005
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
2016 StandoutNobel
Zinc-finger Nuclease Editing of Human cxcr4 Promotes HIV-1 CD4+ T Cell Resistance and Enrichment
2012
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Inducible resistance to Fas-mediated apoptosis in B cells
2000
Novel centrifugal method for simple and highly efficient adenovirus-mediated green fluorescence protein gene transduction into human monocyte-derived dendritic cells
2001
p21 in cancer: intricate networks and multiple activities
2009 Standout
Histone deacetylases and cancer: causes and therapies
2001 Standout
Intracellular Fas Ligand Expression Causes Fas-Mediated Apoptosis in Human Prostate Cancer Cells Resistant to Monoclonal Antibody-Induced Apoptosis
2000
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
2004 Standout
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
2002
The PYRIN domain–only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses
2014
Vitamin D
2005
Apoptosis
2002 Standout
Differential effects of cell cycle regulatory protein p21WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy
2003
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
2006 Standout
Inflammasomes: mechanism of assembly, regulation and signalling
2016 Standout
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Gene Delivery into Primary T Cells: Overview and Characterization of a Transgenic Model for Efficient Adenoviral Transduction
2002
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations
2008 Standout
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Mechanisms and Consequences of Affinity Modulation of Integrin αVβ3 Detected with a Novel Patch-engineered Monovalent Ligand
1999
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
2006 Standout
Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells
2002 Standout
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
2001 Standout
A system for the propagation of adenoviral vectors with genetically modified receptor specificities
1999
Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis
2001
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries
2003
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
MTA3 and the Mi-2/NuRD Complex Regulate Cell Fate during B Lymphocyte Differentiation
2004
25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis
2001
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
VITAMIN D RECEPTOR POLYMORPHISMS AND LETHAL PROSTATE CANCER
1998
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
1998
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Foot-and-Mouth Disease
2004 Standout
Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
2001
Adenovirus Vector Pseudotyping in Fiber-Expressing Cell Lines: Improved Transduction of Epstein-Barr Virus-Transformed B Cells
2000
Transcriptional regulation of adipogenesis
2000 Standout
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
2000
1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
1997
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Tumorigenic Heterogeneity in Cancer Stem Cells Evolved from Long-term Cultures of Telomerase-Immortalized Human Mesenchymal Stem Cells
2005
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
1998
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
2001
Vitamin D and prostate cancer
2001
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
2005 Standout
Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
1998
Vitamin D and cancer: a review of molecular mechanisms
2011
Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.
2003
The Biology of Chromatin Remodeling Complexes
2009 Standout
The Role of Vitamin D in Cancer Prevention
2005 Standout
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Interpretation of europium(III) spectra
2015 Standout
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
Increased Susceptibility to DNA Virus Infection in Mice with a GCN2 Mutation
2011 StandoutNobel
Update on adenovirus and its vectors
2000
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Vitamin D receptor polymorphisms and prostate cancer
2000
The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model
2004
Molecular Genetics and Epidemiology of Prostate Carcinoma
1999
Novel strategies and therapeutics for the treatment of prostate carcinoma
2000
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
2002 Standout
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Differentiation of Effector CD4 T Cell Populations
2010 Standout
Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer
2002
Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
1999
Clinical and Pathological Significance of Vitamin D Receptor Gene Polymorphism for Prostate Cancer which Is Associated with a Higher Mortality in Japanese.
2001
Works of Tammy E. Hedlund being referenced
Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells
1999
Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro
2005
Vitamin D receptor expression is required for growth modulation by 1α,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31
1996
The metabolites citrate, myo‐inositol, and spermine are potential age‐independent markers of prostate cancer in human expressed prostatic secretions
2008
Three-dimensional spheroid cultures of human prostate cancer cell lines
1999
Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro
2002
A serum‐free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines
1994
Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage
1998
Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway
1996
Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31.
2001
Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
1995
Adenoviral-mediated gene transfer in lymphocytes
1998
Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
1997
Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.
1996